Cefetamet pivoxil versus cefixime in the treatment of 99 cases of bacterial infections:a randomized clinical study
万方数据知识服务平台
应用市场
我的应用
会员HOT
万方期刊
×

点击收藏,不怕下次找不到~

@万方数据
会员HOT

期刊专题

Cefetamet pivoxil versus cefixime in the treatment of 99 cases of bacterial infections:a randomized clinical study

引用
Objective To evaluate the safety and efficacy of cefetamet pivoxil in comparison with cefixime in treating bacterial infections. Methods 99 patients with respiratory and urinary tract infections were randomly enrolled. Ten patients were excluded within the first 72 h after initiation of the study. 55 and 54 patients were evaluated for the safety of cefetamet pivoxil and cefixime respectively. 51 patients in the cefetamet pivoxil group and 48 patients in the cefixime group were evaluated for treatment efficacy. The dosage of cefetamet pivoxil was 250-500 mg and cefixime was 200 mg, twice daily orally for 7-10 days. Results The efficacy rates of cefetamet pivoxil and cefixime were 94.1% (48/51) and 91.7% (44/48), and bacterial clearance rates were 95.3% and 95.1%, respectively.Adverse reactions occurred in 9.1% and 7.4% in the two groups respectively. Conclusion There were no statistical differences between the two groups with respect to clinical efficacy, bacterial clearance and adverse reactions profiles.

Cephalosporins、Bacterial infections

37

2021-04-06(万方平台首次上网日期,不代表论文的发表时间)

共4页

81-84

相关文献
评论
暂无封面信息
查看本期封面目录

中华内科杂志

0578-1426

11-2138/R

37

1998,37(zk)

相关作者
相关机构

专业内容知识聚合服务平台

国家重点研发计划“现代服务业共性关键技术研发及应用示范”重点专项“4.8专业内容知识聚合服务技术研发与创新服务示范”

国家重点研发计划资助 课题编号:2019YFB1406304
National Key R&D Program of China Grant No. 2019YFB1406304

©天津万方数据有限公司 津ICP备20003920号-1

信息网络传播视听节目许可证 许可证号:0108284

网络出版服务许可证:(总)网出证(京)字096号

违法和不良信息举报电话:4000115888    举报邮箱:problem@wanfangdata.com.cn

举报专区:https://www.12377.cn/

客服邮箱:op@wanfangdata.com.cn